FDA Drug Application (020164) for LOVENOX by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number020164
Product Number009
FormINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Dosage300MG/3ML (100MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOVENOX
Active IngredientENOXAPARIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient ENOXAPARIN SODIUM4


Back to FDA Applications sponsored by SANOFI AVENTIS US